We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered ... Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered intravenously, that selectively targets all class I isoforms of PI3K and mammalian target of rapamycin (mTOR). Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.4816 | -3.26251896813 | 14.7616 | 15.72 | 13.855 | 687525 | 14.75912161 | CS |
4 | -2.46 | -14.6953405018 | 16.74 | 17.0161 | 13.855 | 373694 | 15.09381124 | CS |
12 | -1.88 | -11.6336633663 | 16.16 | 19.77 | 13.855 | 385598 | 16.6798143 | CS |
26 | -3.65 | -20.3569436698 | 17.93 | 22.188 | 13.715 | 327524 | 16.69526021 | CS |
52 | 4.33 | 43.5175879397 | 9.95 | 22.188 | 8.389 | 236503 | 16.23497619 | CS |
156 | -3.55 | -19.9102636007 | 17.83 | 22.188 | 4.81 | 120207 | 14.22446641 | CS |
260 | -3.34 | -18.9557321226 | 17.62 | 33.01 | 4.03 | 102108 | 16.37625054 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions